Global Pharmaceutical Intermediates Market Growth 2024, Forecast To 2033
8 Mar, 2024
The pharmaceutical intermediates market has seen robust growth, reaching $31.33 billion in 2023, projected to hit $33.59 billion in 2024 at a CAGR of 7.2%. This growth stems from chemical synthesis advancements and increasing demand. Expected growth to $43.01 billion by 2028, with a CAGR of 6.4%, is driven by biopharmaceutical innovation and trends like continuous flow chemistry and automation.
Global Pharmaceutical Intermediates Market Key Driver
The pharmaceutical intermediates market is expanding due to the rising prevalence of chronic diseases globally. With chronic kidney disorders projected to affect 13.4% of the population, there is an increasing demand for medications to manage these conditions. Pharmaceutical intermediates play a vital role in the development and production of these medications, driving growth in the market. The prevalence of chronic diseases highlights the importance of pharmaceutical intermediates in meeting the healthcare needs of the population.
Get A Free Sample Of The Global Pharmaceutical Intermediates Market ReportGlobal Pharmaceutical Intermediates Market Segments
The pharmaceutical intermediates market covered in this report is segmented –
1) Product:Chemical Intermediate, Bulk Drug Intermediate, Other Products
2) Category:Branded Drug Intermediate, Generic Drug Intermediate
3) Application:Analgesics, Anti-Infective Drugs, Cardiovascular Drugs, Oral Antidiabetic Drugs, Antimicrobial Drugs, Other Applications
4) End-User:Biotech And Pharma Companies, Research Institutions, Other End-Users
By Geography: The countries covered in the pharmaceutical intermediates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the pharmaceutical intermediates market in 2023. The regions covered in the pharmaceutical intermediates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Pharmaceutical Intermediates Industry Players
BASF SE; Sanofi SA; Thermo Fisher Scientific Inc; Meck KGaA; Dishman Carbogen Amcis Ltd; Evonik Industries AG; Arkema Inc.; Lonza Group AG; Wuxi AppTec co. Ltd; Aurobindo Pharma Lmited.; Lianhe Chemical Technology Co. Ltd.; Cambrex Corporation; Vertellus Holdings LLC.; Hovione LLC; Hikal Ltd.; Codexis Inc.; Aceto Corporation; Interchem Corporation; Midas Pharma GmbH; Arbiom; Dextra Laboratories Ltd.; A. R. Life Sciences; Ingenza Ltd; Chiracon GmbH; Dyadic International Inc.; Elam Pharma Pvt Ltd; Yin-sheng Bio-tech Co. Ltd.; Green Vision Life Sciences; Sibylla Biotech s.r.l.; Pfizer CentreOne
Get The Full Global Pharmaceutical Intermediates Market Report
Pharmaceutical Intermediates Market Overview
Pharmaceutical intermediates refer to chemical compounds or substances that are used in the synthesis and production of active pharmaceutical ingredients (APIs) or drug substances. It is used by pharmaceutical companies, and research institutions in the development and production of a wide range of drugs and therapeutic products.